Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most adults, pinching a fold of skin before injecting Wegovy is the right technique — it lifts the subcutaneous fat layer away from underlying muscle, so the medicine lands in the correct tissue. Whether it is necessary depends on your body composition and the site you choose, which is why the NHS patient information for semaglutide and Wegovy's own Patient Information Leaflet both advise checking with your healthcare team. Wegovy (semaglutide) is a prescription-only medicine; a GPhC-registered prescriber assesses suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The purpose of pinching is straightforward. Wegovy is injected subcutaneously, into the fat layer sitting just beneath your skin, not into muscle. When that fat layer is thin (as it often is on the outer thigh or upper arm in leaner individuals), inserting a needle without lifting a fold risks going too deep. The Wegovy SmPC, published on the Electronic Medicines Compendium (eMC), specifies subcutaneous administration and instructs patients to follow the detailed steps in the leaflet supplied with each pen. Those steps include forming a skin fold at the injection site before inserting the needle.
The needle on a Wegovy pen is short (designed to reach subcutaneous tissue safely in most adults) but body composition varies considerably. Someone with more subcutaneous fat at the abdomen may inject comfortably without a tight pinch; someone with a thinner abdominal wall will almost certainly need one. If you are unsure whether your technique is right, our guide on whether you should pinch your skin when injecting Wegovy walks through the decision in detail, including how body composition affects the answer.
One misconception worth clearing up gently: many people assume the pen's auto-mechanism means technique doesn't matter. It does. The pen controls depth and dose accurately, but it cannot compensate for where beneath the skin the needle tip actually lands. Your grip on the tissue before you press the plunger is still the critical variable.
The three licensed sites each behave a little differently. The abdomen (at least a couple of centimetres clear of the navel) is the most forgiving because subcutaneous fat there tends to be thicker, giving more margin. Even so, pinching is still the standard recommendation for the abdomen in most injection-training resources.
The outer thigh typically has a thinner fat layer, particularly in people who are more muscular, so a firm pinch is especially important here. The upper arm is the trickiest site for self-injection because creating a proper skin fold with one hand is difficult; it is generally easier when someone else administers the dose, or if you are confident in the technique. If you are learning the upper arm site, our Wegovy injection guide covers positioning in more practical detail.
Rotate sites week to week. Repeated injections into one small area can produce a firm lump under the skin (lipohypertrophy) which is painless but may reduce absorption. If you notice one of these, the guide on lumps after a Wegovy injection explains what they are and when to mention them to your prescriber.
After choosing your spot and forming the pinch, insert the needle at roughly a 45-degree angle if you are using a thin skin fold, or closer to 90 degrees if you have a generous amount of subcutaneous tissue. Hold the pinch steady throughout the injection, then release it before withdrawing the needle. Letting go too early can draw the needle tip toward muscle.
Some stinging or a cold sensation immediately after injection is common. If the burning lingers for more than a few minutes or happens consistently at one site, it is often a sign the injection went intramuscular rather than subcutaneous, adjusting your pinch and angle usually resolves it. The Wegovy burning at injection site page covers this in more detail, including other causes such as alcohol residue from a swab drying insufficiently before you inject.
Prepare each site by cleaning it with an alcohol wipe and allowing it to dry fully before injecting. A still-wet surface can sting sharply and has been linked to mild local irritation. Alcohol swabs are an inexpensive addition to your routine and straightforward to keep in stock.
Beyond technique, nausea and mild gastrointestinal effects are the side effects most people notice first with Wegovy, these relate to the medicine's mechanism rather than injection method. They typically settle as your body adjusts. Report any side effect that concerns you through the MHRA Yellow Card scheme, which monitors the ongoing safety profile of medicines like semaglutide in real-world use.
If you are considering Wegovy as part of a supervised weight-management plan, the Wegovy overview page covers the full picture, licensing, eligibility, and what treatment involves. The cost of private treatment through a regulated pharmacy is one factor people weigh up; the Wegovy cost and sourcing guide sets out what a legitimate private prescription service includes and why the price structure matters for a prescription medicine.
Ready to speak to a clinician? Check your eligibility with our prescribers, the consultation is free, and a named GPhC-registered prescriber reviews every submission the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.